| Full name: VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog | Alias Symbol: VIPAR|VPS16B|SPE-39|SPE39|hSPE-39 | ||
| Type: protein-coding gene | Cytoband: 14q24.3 | ||
| Entrez ID: 63894 | HGNC ID: HGNC:20347 | Ensembl Gene: ENSG00000151445 | OMIM ID: 613401 |
| Drug and gene relationship at DGIdb | |||
Expression of VIPAS39:
| Dataset | Gene | EntrezID | Probe | Log2FC | Adj.pValue | Expression |
|---|---|---|---|---|---|---|
| GSE17351 | VIPAS39 | 63894 | 218431_at | -0.1336 | 0.6100 | |
| GSE20347 | VIPAS39 | 63894 | 218431_at | -0.1215 | 0.3613 | |
| GSE23400 | VIPAS39 | 63894 | 218431_at | 0.0441 | 0.3958 | |
| GSE26886 | VIPAS39 | 63894 | 218431_at | -0.3358 | 0.1450 | |
| GSE29001 | VIPAS39 | 63894 | 218431_at | 0.2945 | 0.0603 | |
| GSE38129 | VIPAS39 | 63894 | 218431_at | -0.1053 | 0.2780 | |
| GSE45670 | VIPAS39 | 63894 | 218431_at | 0.0819 | 0.6375 | |
| GSE53622 | VIPAS39 | 63894 | 48869 | 0.2146 | 0.0278 | |
| GSE53624 | VIPAS39 | 63894 | 48869 | 0.1676 | 0.0490 | |
| GSE63941 | VIPAS39 | 63894 | 218431_at | 0.5719 | 0.0904 | |
| GSE77861 | VIPAS39 | 63894 | 218431_at | -0.2182 | 0.4440 | |
| SRP007169 | VIPAS39 | 63894 | RNAseq | -0.5881 | 0.1312 | |
| SRP008496 | VIPAS39 | 63894 | RNAseq | -0.6049 | 0.0146 | |
| SRP064894 | VIPAS39 | 63894 | RNAseq | 0.2710 | 0.0159 | |
| SRP133303 | VIPAS39 | 63894 | RNAseq | 0.1950 | 0.2627 | |
| SRP159526 | VIPAS39 | 63894 | RNAseq | -0.2407 | 0.4155 | |
| SRP193095 | VIPAS39 | 63894 | RNAseq | -0.0887 | 0.3613 | |
| SRP219564 | VIPAS39 | 63894 | RNAseq | -0.0976 | 0.7814 |
Upregulated datasets: 0; Downregulated datasets: 0.
Survival by VIPAS39 expression:
 |  |
| GSE53622 | GSE53624 |
Note: Click image to view full size file.
Copy number change of VIPAS39:
| Dataset | Gene | EntrezID | Gain | Loss | Normal | Detail |
|---|---|---|---|---|---|---|
| GSE15526 | VIPAS39 | 63894 | 8 | 3 | 19 | |
| GSE20123 | VIPAS39 | 63894 | 8 | 3 | 19 | |
| GSE43470 | VIPAS39 | 63894 | 8 | 3 | 32 | |
| GSE46452 | VIPAS39 | 63894 | 16 | 3 | 40 | |
| GSE47630 | VIPAS39 | 63894 | 11 | 8 | 21 | |
| GSE54993 | VIPAS39 | 63894 | 3 | 8 | 59 | |
| GSE54994 | VIPAS39 | 63894 | 19 | 4 | 30 | |
| GSE60625 | VIPAS39 | 63894 | 0 | 2 | 9 | |
| GSE74703 | VIPAS39 | 63894 | 7 | 3 | 26 | |
| GSE74704 | VIPAS39 | 63894 | 3 | 3 | 14 | |
| TCGA | VIPAS39 | 63894 | 32 | 16 | 48 |
Total number of gains: 115; Total number of losses: 56; Total Number of normals: 317.
Somatic mutations of VIPAS39:
Generating mutation plots.
Highly correlated genes for VIPAS39:
Showing top 20/52 corelated genes with mean PCC>0.5.
| Gene1 | Gene2 | Mean PCC | Num. Datasets | Num. PCC<0 | Num. PCC>0.5 |
|---|---|---|---|---|---|
| VIPAS39 | ZFYVE1 | 0.663613 | 4 | 0 | 4 |
| VIPAS39 | PPCS | 0.657718 | 4 | 0 | 3 |
| VIPAS39 | ACTR10 | 0.62131 | 6 | 0 | 5 |
| VIPAS39 | ISCA2 | 0.615003 | 5 | 0 | 4 |
| VIPAS39 | CHMP4B | 0.597801 | 4 | 0 | 3 |
| VIPAS39 | TTLL5 | 0.593902 | 9 | 0 | 6 |
| VIPAS39 | C1orf50 | 0.584704 | 6 | 0 | 3 |
| VIPAS39 | CRBN | 0.579475 | 3 | 0 | 3 |
| VIPAS39 | CPT2 | 0.573632 | 4 | 0 | 3 |
| VIPAS39 | PSEN1 | 0.57358 | 9 | 0 | 6 |
| VIPAS39 | FOXN3 | 0.572569 | 3 | 0 | 3 |
| VIPAS39 | TESK2 | 0.569006 | 4 | 0 | 3 |
| VIPAS39 | TMED10 | 0.568023 | 9 | 0 | 6 |
| VIPAS39 | MRPL37 | 0.567824 | 4 | 0 | 3 |
| VIPAS39 | NPC2 | 0.567676 | 7 | 0 | 6 |
| VIPAS39 | GLRX5 | 0.559399 | 5 | 0 | 4 |
| VIPAS39 | EIF2B2 | 0.558536 | 8 | 0 | 4 |
| VIPAS39 | LRRC47 | 0.554559 | 5 | 0 | 4 |
| VIPAS39 | NAA30 | 0.554224 | 6 | 0 | 4 |
| VIPAS39 | NME7 | 0.553058 | 5 | 0 | 3 |
For details and further investigation, click here
